Barclays Reiterates Equal-Weight Rating on DaVita Inc. (DVA)

Market Context

DaVita Inc. operates in the Healthcare sector. The stock currently trades at $188.69 with a market capitalization of $8.5B. The stock has gained 63.6% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for DaVita Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for DaVita Inc.

Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 05, 2026	Barclays	Equal-Weight	N/A
Jul 14, 2026	Truist Securities	Hold	N/A
Jul 10, 2026	UBS	Buy	N/A
Jul 09, 2026	Barclays	Equal-Weight	N/A
May 11, 2026	TD Cowen	Hold	N/A

Related Tools: Analyst Ratings Dashboard | View DVA Stock Page